Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

Inclusion Criteria: * Be at least 18 years of age. * Provide written informed consent. * Be willing and able to comply with all study procedures. * Have a history of dry eye disease for at least 6 months prior to Visit 1. Exclusion Criteria: * Have any clinically significant slit-lamp findings at least one eye at Visit 1 that may include active blepharitis, meibomian gland dysfunction, lid margin inflammation, or active ocular allergies that require therapeutic treatment, and/or in the opinion of the Investigator may interfere with study parameters. * Be diagnosed with an ongoing ocular infection (bacterial, viral, or fungal), or active ocular inflammation in at least one eye at Visit 1 or Visit 2. * Have worn contact lenses within 7 days of Visit 1 or anticipate using contact lenses in the study eye during the study. * Additional inclusion/exclusion criteria apply.